Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mouth spray could curb cold virus spread, early trial hints

NCT ID NCT07041671

First seen Apr 24, 2026 · Last updated Jun 23, 2026 · Updated 5 times

Summary

This study tests whether ColdZyme mouth spray can lower the amount of virus people with cold or flu symptoms breathe out. Researchers will measure virus particles in exhaled air before and after using the spray. The goal is to see if the spray might help reduce airborne transmission of respiratory viruses.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UPPER RESPIRATORY TRACT INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Lund University

    RECRUITING

    Lund, 22100, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ColdZyme mouth spray (a medical device that forms a protective barrier in the mouth and throat)

What this could lead to

If it works, this could show that a simple mouth spray helps reduce the spread of cold and flu viruses from infected people to others.

What could go wrong

This is an early-stage study with only one dose, and it measures virus levels in breath, not actual infection rates. The spray may not meaningfully reduce transmission in real-world settings.

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder viral respiratory tract infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.